Department of Medicine and Aging Sciences, University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.
Center for Advanced Studies and Technology (CAST), University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.
Int J Mol Sci. 2022 Nov 29;23(23):14913. doi: 10.3390/ijms232314913.
Platelet-rich plasma (PRP) has great potential in regenerative medicine. In addition to the well-known regenerative potential of secreted growth factors, extracellular vesicles (EVs) are emerging as potential key players in the regulation of tissue repair. However, little is known about their therapeutic potential as regenerative agents. In this study, we have identified and subtyped circulating EVs (platelet-, endothelial-, and leukocyte-derived EVs) in the peripheral blood of athletes recovering from recent muscular injuries and undergoing a submaximal strength rehabilitation program. We found a significant increase in circulating platelet-derived EVs at the end of the rehabilitation program. Moreover, EVs from PRP samples were isolated by fluorescence-activated cell sorting and analyzed by label-free proteomics. The proteomic analysis of PRP-EVs revealed that 32% of the identified proteins were associated to "defense and immunity", and altogether these proteins were involved in vesicle-mediated transport (GO: 0016192; FDR = 3.132 × 10), as well as in wound healing (GO: 0042060; FDR = 4.252 × 10) and in the events regulating such a process (GO: 0061041; FDR = 2.812 × 10). Altogether, these data suggest that platelet-derived EVs may significantly contribute to the regeneration potential of PRP preparations.
富含血小板的血浆 (PRP) 在再生医学中有很大的潜力。除了众所周知的分泌生长因子的再生潜力外,细胞外囊泡 (EVs) 作为调节组织修复的潜在关键因素正在出现。然而,关于它们作为再生剂的治疗潜力知之甚少。在这项研究中,我们已经鉴定和分型了运动员在康复期的外周血中的循环 EVs(血小板、内皮和白细胞衍生的 EVs),这些运动员最近经历了肌肉损伤并正在进行亚最大强度的康复计划。我们发现在康复计划结束时,循环血小板衍生的 EVs 显著增加。此外,通过荧光激活细胞分选从 PRP 样本中分离 EVs,并通过无标记蛋白质组学进行分析。PRP-EVs 的蛋白质组学分析表明,32%的鉴定蛋白与“防御和免疫”有关,这些蛋白共同参与囊泡介导的运输(GO: 0016192;FDR = 3.132×10),以及伤口愈合(GO: 0042060;FDR = 4.252×10)和调节这一过程的事件(GO: 0061041;FDR = 2.812×10)。总之,这些数据表明血小板衍生的 EVs 可能对 PRP 制剂的再生潜力有重要贡献。